Dr. Wu Skincare Co., Ltd. - Laporan Laba Rugi (TTM)

Dr. Wu Skincare Co., Ltd.
TW ˙ TPEX ˙ TW0006523004
NT$ 148.00 ↓ -2.50 (-1.66%)
2024-10-25
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Dr. Wu Skincare Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 791 765 819 913 1,014 1,106 1,126 1,056 950 927 944 1,015 1,088 1,137 1,211 1,221 1,227 1,242 1,240 1,219
Change (%) -3.37 7.08 11.56 10.99 9.10 1.80 -6.17 -10.08 -2.44 1.91 7.48 7.16 4.53 6.52 0.78 0.53 1.19 -0.18 -1.63
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 229 250 268 312 369 412 415 370 305 269 265 291 312 323 341 341 353 364 367 365
Change (%) 8.99 7.42 16.40 18.17 11.62 0.92 -11.04 -17.43 -11.92 -1.26 9.48 7.37 3.58 5.47 0.08 3.43 3.09 0.90 -0.61
% of Revenue 28.95 32.64 32.75 34.17 36.38 37.22 36.90 34.99 32.12 29.00 28.10 28.62 28.68 28.42 28.14 27.94 28.75 29.29 29.60 29.91
Gross Operating Profit 562 515 551 601 645 694 710 687 645 658 679 725 776 814 870 880 874 878 873 855
Change (%) -8.40 6.92 9.20 7.27 7.65 2.31 -3.32 -6.12 2.05 3.20 6.70 7.08 4.92 6.94 1.05 -0.60 0.43 -0.62 -2.06
% of Revenue 71.05 67.36 67.25 65.83 63.62 62.78 63.10 65.01 67.88 71.00 71.90 71.38 71.32 71.58 71.86 72.06 71.25 70.71 70.40 70.09
SG&A 285 266 274 280 292 308 302 294 145 278 290 299 458 315 319 329 331 341 338 348
Change (%) -6.41 3.07 1.88 4.52 5.37 -2.01 -2.72 -50.74 92.35 4.12 3.37 52.89 -31.19 1.42 2.88 0.67 3.08 -0.78 2.79
% of Revenue 35.96 34.83 33.52 30.61 28.83 27.84 26.80 27.79 15.22 30.01 30.66 29.49 42.08 27.69 26.37 26.92 26.96 27.46 27.30 28.52
R&D 12 11 11 11 11 10 10 9 8 7 7 7 8 9 10 11 11 12 11 11
Change (%) -2.95 -5.62 -1.13 -0.62 -4.81 -0.88 -5.81 -9.45 -14.54 -5.11 5.21 10.11 14.59 11.92 5.71 3.09 8.73 -5.80 -4.48
% of Revenue 1.48 1.48 1.31 1.16 1.04 0.91 0.88 0.89 0.89 0.78 0.73 0.71 0.73 0.80 0.84 0.88 0.91 0.97 0.92 0.89
OpEx 529 527 553 602 668 730 727 672 606 554 562 597 630 647 670 680 695 717 717 723
Change (%) -0.33 4.94 8.86 10.88 9.25 -0.34 -7.52 -9.92 -8.52 1.39 6.28 5.52 2.71 3.59 1.50 2.09 3.17 -0.01 0.94
% of Revenue 66.86 68.96 67.58 65.94 65.88 65.97 64.59 63.66 63.77 59.79 59.49 58.83 57.92 56.91 55.35 55.74 56.61 57.72 57.82 59.33
Operating Income 262 237 265 311 346 376 399 384 344 373 383 418 458 490 541 540 532 525 523 496
Change (%) -9.49 11.83 17.18 11.22 8.79 5.94 -3.71 -10.35 8.27 2.67 9.25 9.52 7.04 10.39 -0.12 -1.44 -1.39 -0.40 -5.15
% of Revenue 33.14 31.04 32.42 34.06 34.12 34.03 35.41 36.34 36.23 40.21 40.51 41.17 42.08 43.09 44.65 44.26 43.39 42.28 42.18 40.67
Interest Expense -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -0 -0 -0 -0 -0 -0 -0 -1 -1 -2
Change (%) -5.85 -6.02 -6.40 -6.96 -7.35 -7.80 -8.46 -9.40 -10.73 -12.40 -14.16 -17.27 -20.56 -26.27 -35.64 289.26 73.46 41.98 29.40
% of Revenue -0.13 -0.13 -0.11 -0.10 -0.08 -0.07 -0.06 -0.06 -0.06 -0.06 -0.05 -0.04 -0.03 -0.02 -0.02 -0.01 -0.04 -0.07 -0.09 -0.12
Net Income 214 661 695 706 741 296 323 351 328 340 331 362 407 425 485 478 448 476 469 389
Change (%) 208.44 5.12 1.56 5.02 -60.03 8.88 8.69 -6.40 3.61 -2.54 9.18 12.47 4.39 14.13 -1.33 -6.28 6.24 -1.57 -16.99
% of Revenue 27.09 86.46 84.88 77.27 73.12 26.78 28.65 33.18 34.54 36.68 35.08 35.64 37.40 37.35 40.02 39.18 36.53 38.35 37.82 31.91

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista